Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/1993
10/28/1993CA2133659A1 Pyrimidinyl acetamides as elastase inhibitors
10/28/1993CA2133658A1 Heterocyclic derivatives
10/28/1993CA2133657A1 Substituted derivatives
10/28/1993CA2132543A1 Lactam dipeptides having hle inhibiting activity
10/28/1993CA2118503A1 Peptides having tachykinin antagonist activity
10/28/1993CA2118250A1 Lactam peptides having hle inhibiting activity
10/27/1993EP0566919A1 2,4-dioxoimidazoline derivatives
10/26/1993US5256677 Enzyme inhibitor for treating acquired immune deficiency syndrome
10/26/1993CA1323726C Chromogenic compounds, a process for their preparation, and their use
10/20/1993EP0566237A2 Retroviral protease inhibitors
10/20/1993EP0566157A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension
10/20/1993EP0565896A2 Derivatives of aspartic acid, preparation and use thereof
10/19/1993US5254682 Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
10/19/1993US5254579 N-(5-thioxo-L-prolyl)-L-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
10/19/1993US5254558 Treating respiratory system and cardiovascular disorders
10/19/1993CA1323301C Thyrotropin-releasing hormone analogs in cns injury
10/16/1993CA2093989A1 Reagent and catalytic process for clearing a protected function
10/14/1993WO1993020102A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
10/14/1993WO1993020101A1 Inhibitor of protein kinase c
10/14/1993WO1993020100A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993WO1993020099A2 Cck and/or gastrin receptor ligands
10/14/1993WO1993020067A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993CA2133569A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993CA2132516A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
10/14/1993CA2132341A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/13/1993EP0565484A2 HIV-protease inhibiting morpholin- and thiomorpholin-4-ylamides
10/13/1993EP0565450A1 Use of peptide derivatives for the manufacture of medicaments inhibiting endopeptidases 24.15 and 24.16
10/13/1993EP0565396A1 1-(2-arylsulfonylamino)-1-oxoethyl)-piperidine derivatives, their preparation and use in therapy
10/13/1993EP0565148A2 Intermediates for preparation of H-Arg-X-Y-Z-Tyr-R
10/13/1993EP0564924A2 2-Oxoethyl derivatives as immunosuppressants
10/13/1993EP0564587A1 Solution phase process for synthesis of peptide
10/13/1993EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters
10/13/1993EP0564533A1 Modified penta- and hexapeptide anaphylatoxin receptor ligands
10/13/1993EP0233197B1 Water soluble xanthylium derivative substrates
10/13/1993CN1022412C Method for preparing urethane-protected amino acid-N-carboxyanhydrides
10/12/1993US5252706 Oligopeptides with protecting groups, a straight-chain or branched alkyl propyl ether; nonleakage
10/12/1993US5252566 Antithrombotic agents
10/12/1993US5252560 Cyclic imide derivatives, compositions and use
10/09/1993CA2091194A1 2-oxo-ethyl derivatives as immunosuppressants
10/06/1993EP0563329A1 Angiogenic peptides
10/06/1993CN1076928A 1-(2-arylsulfon amido)-1-oxyethyl) piperidine derivatives and their preparation and use in therapy
10/05/1993US5250720 Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
10/05/1993US5250666 Medical diagnosis and therapy; antitumor and anticarcinogenic agents; target localization
10/05/1993US5250660 Reverse phase high pressure liquid chromatography, elution with gradient of acetonitrile in dilute sulfuric acid, adjusting pH with basic ion exchange resin, separating, drying
10/05/1993US5250517 Hypotensive and cardiotonic agents; cardiac insufficiency
10/05/1993US5250414 Diagnostic methods using neurite growth regulatory factors
10/05/1993CA1322715C Use of a tripeptide and composition thereof as an immunostimulating agent
10/02/1993CA2093109A1 Morpholin- and thiomorpholin-4-ylamides
10/01/1993CA2092867A1 1-¬2-(arylsulfonylamine)-1-oxoethyl|piperidine derivatives, their preparation and therapeutic applications
09/1993
09/30/1993WO1993019037A1 Compounds
09/29/1993EP0562659A1 Process to synthetise peptides and new intermediates thereof
09/29/1993EP0562025A1 Very large scale immobilized polymer synthesis
09/29/1993EP0561877A1 Compounds and compositions which inhibit bone resorption
09/29/1993EP0561827A1 Tetrapeptides deriving from dalbaheptide antibiotics.
09/29/1993CN1076690A Sulfonamidocarboxamides
09/28/1993US5248820 Methenylation, hydrolysis, oxidation with chromic acid and catalytic hydrogenation
09/28/1993US5248806 Method of preparing α-L-aspartyl-L-phenylalanine methyl ester
09/28/1993US5248770 Molecular probes for adenosine receptors
09/28/1993CA1322626C Process for the preparation of aspartylphenylalanine methyl ester from n-formylaspartylphenylalanine methyl ester
09/28/1993CA1322521C Thyrotropin-releasing hormone analog composition and use thereof
09/22/1993EP0561303A2 Conjugates of phenylalanine-glycine with antitumor substances
09/22/1993EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins
09/22/1993EP0382842B1 Nootropic
09/21/1993US5246830 Enzymatic process for the determination of β-lactam antibiotics
09/16/1993WO1993018185A1 Receptor internalization signals
09/16/1993WO1993018060A1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
09/16/1993WO1993018059A2 L-thiazolidine-4-carboxylic acid derivative, processes for the preparation thereof and the use thereof in therapy
09/16/1993WO1993018058A1 Peptides mimics useful as platelet aggregation inhibitors
09/16/1993WO1993018057A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
09/16/1993WO1993018056A1 Isosteric antiherpes peptide derivatives
09/16/1993WO1993018023A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them
09/16/1993WO1993017714A1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
09/16/1993WO1993017699A1 Lymphocyte activity regulation by hla peptides
09/16/1993WO1993017671A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
09/16/1993CA2131382A1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
09/16/1993CA2131367A1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
09/16/1993CA2131299A1 Lymphocyte activity regulation by hla peptides
09/16/1993CA2131024A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
09/16/1993CA2130100A1 Receptor internalization signals
09/16/1993CA2129145A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them
09/15/1993EP0560730A2 New derivatives of beta-amino acids with anti-thrombotic activity
09/15/1993EP0560274A1 Antiherpes peptide derivatives having a ureido N-terminus
09/15/1993EP0560267A1 Isosteric antiherpes peptide derivatives
09/15/1993EP0559793A1 Hiv protease inhibitors
09/15/1993EP0317645B1 4h-3,1-benzoxazin-4-one compounds and serine protease-inhibiting medicinal composition containing same
09/15/1993EP0276278B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier
09/15/1993CN1076200A New derivatives of beta-amino acids
09/15/1993CN1076199A 新的肽衍生物 New peptide derivatives
09/15/1993CA2159661A1 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives
09/15/1993CA2159660A1 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives
09/15/1993CA2091316A1 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives
09/14/1993US5245079 Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
09/14/1993US5244889 Treatment of cardiovascular disorders
09/14/1993US5244884 Tripeptide
09/14/1993CA2091151A1 Retroviral protease inhibitors
09/11/1993CA2091292A1 New derivatives of .beta.-amino acids
09/09/1993DE4207254A1 4-oxo-2-thioxoimidazolidin-derivate 4-oxo-2-thioxoimidazolidin-derivatives
09/08/1993EP0559046A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors
09/08/1993EP0558681A1 Treatment for tissue ulceration
09/08/1993EP0558648A1 Improved matrix metalloprotease inhibitors
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 307